Search
keratin antibody in serum
Indications:
- evaluation of rheumatoid arthritis
Clinical significance:
- 36-59% of patients with rheumatoid arthritis have anti-keratin antibody compared with 0-3% of healthy individuals
- anti-keratin antibody specificity
- AE1/AE3: pankeratin
- AE1: CK10/CK11/CK13/CK14/CK15/CK16/CK19 (low molecular weight keratins)
- AE3: high molecular weight keratins
- CAM5.2: anti-keratin 8/18
- 35 beta H11: anti-keratin 18
- 34 beta E12 (CK903): CK1/CK5/CK10/CK14
- basal cell specific
- basal cells of prostate
- spurious keratin immunoreactivity has been described in glial cells & neoplasms with AE1/AE3 & 34 beta E12 antibodies.
- CAM 5.2 does not react with astroglial cells
Methods:
- anti-keratin antibodies react against the stratum corneum of rat esophagus
Related
anti-keratin antibody
keratin
General
serology
References
- Clinical Diagnosis & Management by Laboratory Methods,
19th edition, J.B. Henry (ed), W.B. Saunders Co.,
Philadelphia, PA. 1996, pg 1020
- Dabbs. Diagnostic Immunohistochemistry. Churchill-Livingstone,
2002. page 168, 174.